Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative

Details for Australian Patent Application No. 2009254548 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Messerschmid, Roman; Bock, Thomas; Binder, Rudolf; Brox, Werner

Agent Spruson & Ferguson

Pub. Number AU-A-2009254548

PCT Pub. Number WO2009/147212

Priority 08157748.8 06.06.08 EP

Filing date 4 June 2009

Wipo publication date 10 December 2009

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 31/404 (2006.01)

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/147212 Priority application(s): WO2009/147212

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009254550-Inorganic nanoparticles of high density to destroy cells in-vivo

2009254547-New compounds V